SLC7A11 protects luminal A breast cancer cells against ferroptosis induced by CDK4/6 inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SLC7A11 protects luminal A breast cancer cells against ferroptosis induced by CDK4/6 inhibitors

Published:2024-10 Issue: Volume:76 Page:103304
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Cui Yingshu,Li Yi,Xu Yuanyuan,Liu Xinxin,Kang Xiaofeng,Zhu Junwen,Long Shan,Han Yuchen,Xue Chunyuan,Sun Zhijia,Du Yimeng,Hu Jia,Pan Lu,Zhou Feifan,Xu Xiaojie,Li Xiaosong^ORCID

Funder

National Aerospace Science Foundation of China

Publisher

Elsevier BV

Reference54 articles.

1. miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs;Riaz;Breast Cancer Res.,2013

2. Defining breast cancer intrinsic subtypes by quantitative receptor expression;Cheang;Oncol.,2015

3. Palbociclib and letrozole in advanced breast cancer;Finn;N. Engl. J. Med.,2016

4. Ribociclib as first-line therapy for HR-positive, advanced breast cancer;Hortobagyi;N. Engl. J. Med.,2016

5. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro;Finn;Breast Cancer Res.,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP